[Translational research of novel PAI-1 inhibitors]

Nihon Yakurigaku Zasshi. 2010 Dec;136(6):340-3. doi: 10.1254/fpj.136.340.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Cerebral Infarction / prevention & control
  • Drug Design
  • Humans
  • Myocardial Ischemia / prevention & control
  • Piperazines
  • Plasminogen Activator Inhibitor 1* / pharmacokinetics
  • Plasminogen Activator Inhibitor 1* / pharmacology
  • Plasminogen Activator Inhibitor 1* / therapeutic use
  • Plasminogen Activator Inhibitor 1* / toxicity
  • Serine Proteinase Inhibitors* / pharmacokinetics
  • Serine Proteinase Inhibitors* / pharmacology
  • Serine Proteinase Inhibitors* / therapeutic use
  • Serine Proteinase Inhibitors* / toxicity
  • Translational Research, Biomedical*
  • para-Aminobenzoates

Substances

  • 5-chloro-2-(((2-(4-(diphenylmethyl)piperazin-1-yl)-2-oxoethoxy)acetyl)amino)benzoate
  • Piperazines
  • Plasminogen Activator Inhibitor 1
  • Serine Proteinase Inhibitors
  • para-Aminobenzoates